ISRCTN ISRCTN85999967
DOI https://doi.org/10.1186/ISRCTN85999967
Secondary identifying numbers 32003B_182681
Submission date
05/08/2020
Registration date
13/08/2020
Last edited
18/09/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Stroke is a major cause of death and the risk of stroke increases with age. If survived, stroke is the most common cause of disability in adults. Stroke often results in permanent limitations of mobility, and the need for the help of others in activities of daily living. Up to now, little is known about the recovery of mobility after stroke. In order to optimize the rehabilitation after stroke, detailed knowledge of the recovery process regarding mobility is needed. People’s life-space mobility (i.e. their mobility in the environment), has not been investigated yet. This study aims to close this knowledge gap. Innovative data collection methods including wearable sensors and interactive digital maps will be used.

The study aims to describe mobility, including mobility function and life-space mobility, and changes in mobility within the first year after stroke. The study also aims to identify and describe subgroups with different recovery patterns of mobility; to evaluate if a change in mobility function goes along with a change in life space mobility; nad to evaluate patients’ motivation for going outdoors, transportation use, as well as assistance needed.

Who can participate?
Patients aged 18 years or older who are treated at the Stroke Center, University Hospital Basel with a first stroke can participate in this study. Patients with severe cognitive impairment or physical disability cannot participate in this study.

What does the study involve?
At 3, 6, 9, and 12 months after stroke, different mobility tests will be performed at the study center, including tests of balance, strength, and gait. The life space (physical area used/visted by participants) will be measured in participants’ real life using GPS. In addition, participants will give information on visited locations including motivation for travel, use of transportation, and assistance needed by using interactive digital maps.

What are the possible benefits and risks of participating?
The study is purely observational. There are neither specific risks nor direct (health) benefits for the participants. A detailed knowledge of recovery patterns after stroke will help to improve the rehabilitation process for future patients. Knowledge about patients’ motivation for outdoor mobility will allow to define individualized patient-oriented rehabilitation goals.

Where is the study run from?
The study will be run from the Department of Sport, Exercise, and Health, University of Basel (Switzerland) with participants recruited from the Department of Neurology & Stroke Center, University Hospital Basel (Switzerland) and measurements taken at the Basel Mobility Center, Department of Geriatric Medicine Felix Platter (Switzerland)

When is the study starting and how long is it expected to run for?
January 2018 to February 2022

Who is funding the study?
The project is financed by the Swiss National Science Foundation (Switzerland), Project-No. 182681

Who is the main contact?
1. PD Dr. med. Timo Hinrichs
timo.hinrichs@unibas.ch
2. Prof. Dr. Nils Peters
nils.peters@usb.ch

Study website

Contact information

Dr Timo Hinrichs
Scientific

Division of Sports and Exercise Medicine
Department of Sport, Exercise and Health (DSBG)
University of Basel
Birsstrasse 320 B
Basel
4052
Switzerland

ORCiD logoORCID ID 0000-0001-6200-307X
Phone +41 61 207 47 43
Email timo.hinrichs@unibas.ch
Prof Nils Peters
Scientific

Department of Neurology & Stroke Center
University Hospital Basel
Petersgraben 4
Basel
4031
Switzerland

Phone +41 61 556 58 53
Email nils.peters@usb.ch

Study information

Study designSingle-centre prospective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleRecovery of mobility function and life-space mobility after ischemic stroke (MOBITEC-Stroke)
Study acronymMOBITEC-Stroke
Study objectivesIn order to be able to design rehabilitative measures for people after stroke and to maximize their effectiveness, knowledge of the details of stroke recovery (including timing and components) and of the association between mobility function and life-space mobility during the recovery process is needed.
Ethics approval(s)Approved 16/12/2019, The Ethics Committee of Northwestern and Central Switzerland (EKNZ) (Hebelstrasse 53, 4056 Basel, Switzerland; +41 061 268 13 50; eknz@bs.ch), ref: 2019-00989
Health condition(s) or problem(s) studiedIschemic stroke (first event)
InterventionPatients with incident first stroke who live in their own homes will be included in this cohort study. At 3, 6, 9, and 12 months after stroke a battery of mobility tests will be performed at the study centre, including laboratory-based tests of balance and strength, and quantitative gait analysis. Life-space assessment (including 1-week GPS measurements) will be performed in participants’ real life. Semantic information on visited locations (reasons for going outdoors, transportation use, assistance needed) will be collected by using interactive digital maps. Linear mixed-effects models will be used to model the trajectories of mobility measures for the total sample and for predefined subgroups. As an exploratory analysis, growth mixture models (GMMs) will be used to identify relevant subgroups with different trajectories. Linear mixed effect models will be used to test whether changes in lower extremity physical function parameters are associated with changes in life-space. Participants’ motivation for going outdoors, transportation use, and assistance needed for outdoor mobility will be analysed descriptively. Furthermore, clinical information for the time of the first admission to the Stroke Centre will be made available.
Intervention typeOther
Primary outcome measure1. Walking ability and perceived mobility limitation assessed by self-report at 3, 6, 9, and 12 months after stroke
2. Lower extremity physical function measured using a battery of tests including quantitative gait analysis, tests of lower limb muscle power, balance tests and functional tests in a given order at the study centre assessed at 3, 6, 9, and 12 months after stroke
3. Life-space measured using GPS and by self-report questionnaire at 3, 6, 9, and 12 months after stroke
4. Reasons for going outdoors, transportation use, and need for assistance measured using a questionnaire tool that is based on digital maps at 3, 6, 9, and 12 months after stroke
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/01/2018
Completion date08/02/2022

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants59
Total final enrolment59
Key inclusion criteria1. First ischemic stroke within the past 3 months
2. Aged ≥18 years
3. Able to communicate verbally with the study personnel
4. Able to understand the study information and to provide written informed consent
5. At least one of the following stroke-related symptoms potentially affecting gait/mobility must be present:
5.1. Lower limb paresis or ataxia
5.2. Stance/gait ataxia (cerebellar or sensory)
5.3. Visual disturbance/field defect
5.4. Central vestibular deficit
5.5. Attentional deficit/neglect
6. Able to get up from a chair and sit down without external help
7. Able to walk for a minimum of 20 m at own pace, with or without pauses, with or without a walking aid, but without the physical assistance of another person (self-report)
Key exclusion criteria1. Not community-dwelling
2. Unable to walk without assistance, wheelchair-bound, or permanently bedridden (modified Rankin Scale, mRS >3 points)
3. Presence of severe cognitive impairment (Montreal Cognitive Assessment (MoCA) score <21 or, <20 for persons with 12 years of education or less)
4. Acute psychiatric disorder (e.g. severe depression)
5. Advanced terminal illness
6. Orthopaedic surgery of the lower extremities within the past year
7. On-going rehabilitation measures following an inpatient surgical procedure at the time of stroke
8. Major pre-stroke mobility limitations (major difficulties in walking or climbing stairs; self-report)
Date of first enrolment01/01/2020
Date of final enrolment22/06/2021

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Basel Mobility Center
Department of Geriatric Medicine Felix Platter
Burgfelderstrasse 101
Basel
4055
Switzerland

Sponsor information

University of Basel
University/education

Division of Sports and Exercise Medicine
Department of Sport, Exercise and Health (DSBG)
University of Basel
Birsstrasse 320 B
Basel
4052
Switzerland

Phone +41 61 207 47 43
Email timo.hinrichs@unibas.ch
Website https://www.unibas.ch/de
ROR logo "ROR" https://ror.org/02s6k3f65

Funders

Funder type

Government

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Schweizerischer Nationalfonds, Swiss National Science Foundation, Fonds National Suisse de la Recherche Scientifique, Fondo Nazionale Svizzero per la Ricerca Scientifica, Fonds National Suisse, Fondo Nazionale Svizzero, Schweizerische Nationalfonds, SNF, SNSF, FNS
Location
Switzerland

Results and Publications

Intention to publish date30/09/2022
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publications in peer-reviewed scientific journals.
IPD sharing planData will be made freely available to external research groups by sharing them through a digital repository. Details of the data sharing plans are unknown and will be made available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 16/09/2020 21/09/2020 Yes No
Results article results 04/05/2023 09/05/2023 Yes No
Results article 22/12/2022 18/09/2024 Yes No

Editorial Notes

18/09/2024: Publication reference added.
09/05/2023: Publication reference added.
15/03/2022: The following changes were made to the trial record:
1. Total final enrolment added.
2. The recruitment end date was changed from 31/12/2020 to 22/06/2021.
3. The overall trial end date was changed from 31/03/2022 to 08/02/2022.
4. The intention to publish date was changed from 31/03/2022 to 30/09/2022.
5. Trial website added.
21/09/2020: Publication reference added.
10/08/2020: Trial’s existence confirmed by the Swiss National Science Foundation.